Predicting flu vaccine effectiveness

Veljko Veljkovic, Biomed Protection, and Slobodan Paessler, Galveston National Laboratory, have published articles on F1000Research in which they predicted the effectivemess of the flu vaccine in 2017/2018 and 2018/2019. In this guest blog they explain how they went about this and how accurate their predictions were.

Highlighting innovations and challenges for a TB-free world

To mark World TB Day, we launch a collection that we hope will grow over the coming months to highlight the results of could help influence decisions taken by leaders during this year’s UN General Assembly. We also speak to one of the advisors for the collection – Helen Fletcher from London School of Hygiene and Tropical Medicine.

Informed consent in trials of genetically modified mosquitoes – an author and reviewer in conversation – Part 2

An Open Letter published by Pamela Kolopack, University of Toronto and James Lavery, Emory University, on Gates Open Research discussed issues around informed consent in field trials of genetically modified mosquitoes. The article was openly peer reviewed by Carolyn Neuhaus,  The Hastings Centre, after publication. Last week we published the first part of this post in which James and Carolyn discussed topics raised in James’ article. This week they discuss open peer review, institutional review board s and mechanism of authorisation.  

World AIDS Day: Interview with Robert Gallo

Today is annual World AIDS Day: an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died. We spoke to one of the Heads of our Infectious Diseases Faculty, Dr. Robert C. Gallo, who became world famous in 1984 for the co-discovery…

Michelle Leach on Candida Albicans and thermo-pathogenicity

The fungal pathogen Candida albicans is one of the most persistent yeast pathogens known to man. Most people associate it only with thrush, but, as Michelle Leach explains in the video below, it is actually the fourth most common hospital-acquired bloodstream infection and has a mortality rate of 40-70%. Michelle is a post-doctoral researcher at…

Featured F1000Prime Report: developing tools for malaria surveillance.

From this month’s batch of F1000Prime Reports, the peer-reviewed open-access review series on emerging themes in biology and medicine, we thought we’d feature a report dealing with one of the deadliest killers in human history: malaria. In “Research priorities for the development and implementation of serological tools for malaria surveillance“, James Beeson and colleagues take…

Joep Lange

It is with great sadness that we note the tragic death of Professor Joep Lange, F1000Prime Section Head for HIV Infection & AIDS: Clinical, in the Malaysian Airline flight MH17 disaster yesterday. Professor Lange was Professor of Internal Medicine at the Academic Medical Centre, University of Amsterdam, and held a number of prestigious positions, including…

Thirty years since the announcement of HIV as the cause of AIDS

Since the first reports of AIDS, approximately 36 million people have died from the disease, with an estimated 35 million living with HIV. Drug therapy consists of HAART, highly active antiretroviral therapy, which slows progression of the disease and lessens risk of death. Today, researchers are closer than ever to finding a functional cure and…